BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Cefoxitin

A semisynthetic cephamycin antibiotic resistant to beta-lactamase.

300+ PubMed studies analyzed · 65 RCTs · Evidence Score: 53.5

Research Domains

Cefoxitin has been studied across 10 research domains including 😴 Sleep, 🧠 Focus & Attention, 🫘 Kidney, 🦠 Gut & Microbiome, ✨ Skin & Hair. The primary research focus is 😴 Sleep with 14% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Cefoxitin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

cefuroxime
4 shared targets
Cefamandole
5 shared targets
Cefmenoxime
3 shared targets
ceftazidime
3 shared targets
Cefprozil
2 shared targets
Ceftibuten
2 shared targets
Cefmetazole
3 shared targets
Cefpodoxime
2 shared targets
cefatrizine
2 shared targets
Cephradine
3 shared targets
Loading evidence profile...

This evidence profile for Cefoxitin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.